2020
Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study
KOCIAN, Roman; Jiri SLAMA; Daniela FISCHEROVA; Anna GERMANOVA; Andrea BURGETOVA et al.Základní údaje
Originální název
Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study
Autoři
KOCIAN, Roman; Jiri SLAMA; Daniela FISCHEROVA; Anna GERMANOVA; Andrea BURGETOVA; Ladislav DUŠEK; Pavel DUNDR; Kristyna NEMEJCOVA; Jiří JARKOVSKÝ ORCID; Silvie SEBESTOVA; Filip FRUHAUF; Lukas DOSTALEK; Tereza BALLASCHOVA a David CIBULA
Vydání
Cancers, BASEL, MDPI, 2020, 2072-6694
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 6.639
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/20:00116113
Organizační jednotka
Lékařská fakulta
UT WoS
000549262500001
EID Scopus
2-s2.0-85085760636
Klíčová slova anglicky
micrometastasis; isolated tumor cells; sentinel lymph node; cervical cancer; pathological ultrastaging; prognostic parameters; risk of recurrence
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 3. 8. 2020 13:42, Mgr. Tereza Miškechová
Anotace
V originále
The data on the prognostic significance of low volume metastases in lymph nodes (LN) are inconsistent. The aim of this study was to retrospectively analyze the outcome of a large group of patients treated with sentinel lymph node (SLN) biopsy at a single referral center. Patients with cervical cancer, stage T1a-T2b, common tumor types, negative LN on preoperative staging, treated by primary surgery between 01/2007 and 12/2016, with at least unilateral SLN detection were included. Patients with abandoned radical surgery due to intraoperative SLN positivity detected by frozen section were excluded. All SLNs were postoperatively processed by an intensive protocol for pathological ultrastaging. Altogether, 226 patients were analyzed. Positive LN were detected in 38 (17%) cases; macrometastases (MAC), micrometastases (MIC), isolated tumor cells (ITC) in 14, 16, and 8 patients. With the median follow-up of 65 months, 22 recurrences occurred. Disease-free survival (DFS) reached 90% in the whole group, 93% in LN-negative cases, 89% in cases with MAC, 69% with MIC, and 87% with ITC. The presence of MIC in SLN was associated with significantly decreased DFS and OS. Patients with MIC and MAC should be managed similarly, and SLN ultrastaging should become an integral part of the management of patients with early-stage cervical cancer.